Diagonal Bio AB (publ) reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 1.18 million compared to SEK 4.57 million a year ago. Revenue was SEK 1.18 million compared to SEK 4.66 million a year ago.
Net loss was SEK 3.02 million compared to SEK 0.226 million a year ago. Basic loss per share from continuing operations was SEK 0.33 compared to SEK 0.06 a year ago.